ACM
AXSM icon

Aster Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Aster Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.53K Buy
+56
New +$9.67K ﹤0.01% 660
2025
Q3 		– Sell
-37
Closed -$3.86K – 973
2025
Q2 		$3.86K Buy
+37
New +$3.92K ﹤0.01% 894
2025
Q1 		– Sell
-128
Closed -$10.8K – 1252
2024
Q4 		$10.8K Buy
+128
New +$11.8K ﹤0.01% 752

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aster Capital Management's AXSM Position: Q1 2026 in Review

Aster Capital Management opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 56 shares worth $6.53K. The stake represents ﹤0.01% of the portfolio and ranks #660 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in AXSM as recently as Q2 2025.

Aster Capital Management first reported a position in AXSM in Q4 2024 and has held it in 3 quarters since. The position peaked at $10.8K in Q4 2024. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Aster Capital Management held 56 shares of Axsome Therapeutics worth $6.53K as of Q1 2026.
  • Axsome Therapeutics was a new Aster Capital Management position in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #660 holding.
  • Aster Capital Management first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Aster Capital Management's Axsome Therapeutics position peaked at $10.8K in Q4 2024.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.